» Dana-Farber Cancer Institute Commences Phase 1 <b>Trial</b> With <b>...</b>
EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation. MKC-1 is currently in multiple Phase 2 clinical…